Metabolic Brain Disease · Nov 17, 2026

Dietary and endogenous fructose metabolism in Alzheimer’s disease: a critical review of mechanistic, preclinical, and epidemiological evidence

By Michoń J, Pujanek P, Hryniewicz WW et al.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide. It is characterized by the accumulation of β-amyloid plaques, the formation of neurofibrillary tangles (NFT’s), synaptic loss, and brain atrophy. Although age and genetic factors, such as the presence of the APOE ε4 allele, remain the main risk factors, increasing attention is being paid to modifiable metabolic factors. Excessive fructose intake may contribute to neurodegeneration through mechanisms involving insulin resistance, oxidative stress, inflammation, mitochondrial dysfunction, and activation of the so-called “fructose survival pathway”. These processes may disrupt brain energy metabolism and increase β-amyloid accumulation, particularly in the hippocampus. Studies suggest that high sugar consumption, especially in the form of sugar-sweetened beverages, may be associated with an increased risk of Alzheimer’s disease. Although the available data are still limited, excessive fructose intake may be associated with the development of Alzheimer’s disease. Further research is needed to more precisely determine its role and the effectiveness of dietary interventions in the prevention of Alzheimer’s disease.

doi.org/10.1007/s11011-026-02018-0Open accessMechanisms

AgingResearch.News